From each excerpt, extract the names of the defendants that are companies.

<example>
Excerpt:   14. Plaintiff, as set forth in the attached cer tification, purchased J uniper securities at  artificially inflated prices dur ing the Class Period and has been damaged upon the revelation of the  alleged corrective disclosure.   15. Defendant Juniper is a Delaware corporation with its headquarters located at 1194 North  Mathilda Avenue, Sunnyvale, CA 94089.  The commo n stock is traded on the New York Stock  Exchange (“NYSE”) under the ticker symbol “JNPR.”  16. Defendant Kevin R. Johnson (“Johnson”) has served as the Company’s Chief Executive  Officer throughout the Class Period.  17. Defendant Pradeep S. Sindhu (“Sindhu”) is  the Company’s Vice Chairman, Chief  Technology Officer and Founder. Defendant Sindhu sold 300,000 shares of the Company’s stock on  August 2, 2013, less than a week before the FCPA investigation was announced, and also sold 52,500  Juniper shares over three trad ing sessions between January 30, 2013 through February 1, 2013.   18. Defendant Robyn M. Denholm (“Denholm”) ha s served as the Company’s Executive  Vice President and Chief Financial O fficer throughout the Class Period.  19. Defendant Gene Zamiska (“Zamiska”) has se rved as the Company’s Vice President,  Finance throughout the Class Period.  Defendant Zamiska served as the Company’s Corporate  Controller through February 26, 2013.  20. The defendants referenced above in ¶¶ 15 – 18 are sometimes referred to herein as the  “Individual Defendants.”  Case3:13-cv-03733-WHO   Document1   Filed08/12/13   Page4 of 20  COMPLAINT FOR VIOLATIONS OF THE FEDERAL SECURITIES LAWS  4 1  2 3 4 5 6  7  8 9  10 11 12  13  14 15 16 17 18  19  20 21 22 23 24  25  26 27 28 
Company defendants: Juniper Networks, Inc.
</example>

<example>
Excerpt: 	 10 	11. 	Plaintiff Ryan Kelly purchased Electronic Arts common stock during the Class Period  11 as described in the Certification attached hereto and incorporated herein by reference and suffered  12 damages thereon. 	 13 	12. 	Defendant Electronic Arts, headquartered in Redwood City, California, develops,  14 markets, publishes and distributes game software content and services. During the Class Period,  15 Electronic Arts had more than 309 million shares of common stock outstanding, which shares traded  16 in an efficient market on the NASDAQ under the ticker symbol "EA." Electronic Arts was followed  17 by scores of stock analysts and stock rating agencies and was constantly in communication with the  18 markets and investors in quarterly conference calls and frequent presentations to investor and analyst  19 conferences. Electronic Arts also filed periodic public reports with the SEC, and regularly issued  20 press releases to the financial press. 	 21 	13. 	Defendant Andrew Wilson ("Wilson") is, and was throughout the Class Period, an  22 executive of Electronic Arts, assuming the position of its Chief Executive Officer ("CEO") and a  23 director of the Company effective September 15, 2013. 	 24 	14. 	Defendant Blake J. Jorgensen ("Jorgensen") is, and was throughout the Class Period,  25 I Electronic Arts' Chief Financial Officer and an Executive Vice President. 	 26 	15. 	Defendant Frank D. Gibeau ("Gibeau") is, and was throughout the Class Period,  27 President of the EA Labels.  28  COMPLAINT FOR VIOLATIONS OF THE FEDERAL SECURITIES LAWS Case3:13-cv-05837   Document1   Filed12/17/13   Page5 of 251  2  3  4  5  6  8  9  10  11  12  13  14  15  16  17  18  19  All  21  22  23  24  25  26  27  28 16. Defendant Patrick Soderlund ("Soderlund") is, and was throughout the Class Period,  I Executive Vice President of the EA Games Label.  17. Defendant Peter Robert Moore ("Moore") is, and was throughout the Class Period,  I Electronic Arts' President and Chief Ope
Company defendants: Electronic Arts Inc.
</example>

<example>
Excerpt:  11. Plaintiff, as set forth in th e attached certification, purchas ed Catalyst securities at  artificially inflated prices dur ing the Class Period and has b een damaged upon the revelation of  the alleged corrective disclosures.  12.  Defendant Catalyst is a Coral Gates, Florida headquartered company located at  355 Alhambra Circle Suite 1500 Coral Gates, FL 33134. The common stock is traded on the  NASDAQ Stock Market ("NASDAQ") unde r the ticker symbol "CPRX."  13. Defendant Patrick J. McEnany ("McEna ny") is the Company’s co-founder, CEO  and President.  14.  Defendant Dr. Hubert E. Huckel M.D.  ("Huckel") is the Company’s co-founder  and one of its directors.  15. Defendant Steven R. Miller Ph. D. ("M iller") is the company’s COO and CSO.  16.  The defendants referenced above in ¶¶ 13- 15 are sometimes referred to herein as  the "Individual Defendants."  DEFENDANTS' WRONGDOING    Background   Case 1:13-cv-23878-UU   Document 1   Entered on FLSD Docket 10/25/2013   Page 4 of 20  5 17. Catalyst is a specialty pharmaceutical company which develops and  commercializes drugs treating orphan (rare) neuromuscular an d neurological diseases.  18. Lambert-Eaton Myasthenic Syndrome (“LEM S”) is an extremely serious disase  which is also extremely rare, afflicting about 3.4 persons per million, and about one to two thousand patients in the United States.  19. FDA rules permit so-called “compassionate use” – use of a drug that has not been  approved by the FDA outside of clinical trials. A patient may be given drugs under a  compassionate use program if the patient may benefit from the treatment, the therapy can be  given safely outside the clinical trial setting, no other alternative therapy is available, and the  drug developer agrees to provide access to the drug.  20. Jacobus is a tiny privat e pharmaceutical company in  New Jersey, with only  dozens of employees, and only 35 as of 2009. Jacobus has b een manufacturing 3,4 DAP and  providing it to patients through a 
Company defendants: Catalyst Pharmaceutical Partners, Inc.
</example>

Excerpt: {{text}}
Company defendants: